High Contributions for Medications in GESY and Patient Reactions
March 28, 2026
Patients are facing high contributions for specific categories of medications under the GESY, raising concerns about access to medicines. The Health Insurance Organization (OAY) has proposed a cap on contributions, but pharmaceutical companies are rejecting it. It is difficult for patients to switch medications due to different active substances, which could worsen their health conditions. Patients are expressing their dissatisfaction and demanding immediate solutions. This situation has arisen due to changes in the GESY medication lists and the expiration of patents.